Daily non-political popular news in brief.

Molecular medical research points to treatment of spinal muscular atrophy

Researchers at the Peninsula Medical School in Exeter, UK, have carried out studies into one of the two survival motor neuron genes that set suffers from SMA apart from the rest of the population.

Read more »

Keywords: molecular, medical, research, points, treatment, spinal, muscular, atrophy, point

« Previous | Next »

Similar news on "Molecular medical research points to treatment of spinal muscular atrophy":

1. Treatment extends survival in mouse model of spinal muscular atrophy
   02-22-2007 · EurekAlert!
   Drug therapy can extend survival and improve movement in a mouse model of spinal muscular atrophy (SMA), new research shows. The study, carried out at the NIH's National Institute of Neurological Disorders and Stroke (NINDS), suggests that similar drugs might one day be useful for treating human SMA.
   Similar news · Read more »
   
2. Drug blocks lethal motor-neuron disease in mice
   02-22-2007 · EurekAlert!
   Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
   Similar news · Read more »
   
3. The CIMA and a Dutch scientific center have found a treatment for porphyria
   03-30-2007 · EurekAlert!
   The Center for Applied Medical Research (CIMA) from the University of Navarra and the Amsterdam Molecular Therapeutics BV (AMT) have demonstrated the pre-clinical effectiveness of a treatment against acute intermittent porphyria. Once the pre-clinical, toxicological and clinical phases are completed, it may be possible to eliminate this disease permanently.
   Similar news · Read more »
   
4. The structural basis of familial hypertrophic cardiomyopathy is revealed
   11-08-2007 · EurekAlert!
   Familial hypertrophic cardiomyopathy, the leading cause of sudden death in athletes and young people, is a genetic heart disorder that is characterized by an increased thickness in tissue of the left ventricle. A study conducted by scientists at the Burnham Institute for Medical Research provides new structural evidence that the disarray at the molecular level caused by the R403Q point mutation in myosin is linked to the characteristic misalignment of muscle cells in FHC.
   Similar news · Read more »
   
5. NIH report on intracranial stent points out need for upcoming large-scale clinical trial
   02-13-2008 · EurekAlert!
   A preliminary study funded by the National Institutes of Health found that a stent designed to open clogged arteries in the brain was successfully deployed in nearly all cases and significantly reduced arterial blockage in the short term. But data on the long-term benefit of the stent, compared to medical treatment alone, were inconclusive, prompting the upcoming launch of a large-scale randomized trial that is expected to provide definitive results.
   Similar news · Read more »
   
6. Getting on your nerves... and repairing them
   02-15-2007 · EurekAlert!
   In a study to be published in the March 2007 issue of the FASEB Journal, scientists from East Carolina University report that a key molecular mechanism, RNA interference (RNAi), plays a role in the regeneration and repair of periphery nerves, which are the nerves located outside of the brain and spinal column. This research may lead to new therapies that manipulate RNAi to treat people with damaged nerves resulting from degenerative disorders and injury.
   Similar news · Read more »
   
7. UD researchers discover technique for repairing gene defect that causes spinal muscular atrophy
   02-11-2008 · EurekAlert!
   Researchers at the University of Delaware have discovered a novel technique -- that acts like a "spell-checker" for correcting a misspelling in the DNA code -- to repair the defective gene that causes spinal muscular atrophy. This hereditary neuromuscular disease is the number-one genetic killer of children under two years old.
   Similar news · Read more »
   
8. Collaborative study to focus on research, education, treatment for children with ADHD
   11-06-2006 · UT Southwestern Medical Center
   UT Southwestern Medical Center, UT Dallas' Center for BrainHealth and Shelton School of Dallas will join forces to conduct an innovative three-year research study aimed at helping children with attention deficit hyperactivity disorder and their families.
   Similar news · Read more »
   
9. Pourquié lab identifies genes involved in formation of vertebral precursors
   11-13-2006 · EurekAlert!
   Mary Lee Dequeant, Ph.D., a Predoctoral Researcher at the Stowers Institute for Medical Research, and Olivier Pourquié, Ph.D., Stowers Institute Investigator and an investigator with the Howard Hughes Medical Institute, are the first and last authors, respectively, on a paper that identifies a network of cyclic genes that shed light on the molecular basis of spine formation in the embryo.
   Similar news · Read more »
   
10. Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease
    12-12-2006 · EurekAlert!
    Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. The research will be published in the December online edition of the journal Annals of Neurology.
    Similar news · Read more »